Evidence map›Paper›PMID 12453312›Full record

ReviewArthritis research2002

Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome.

Thomas Dörner, Peter E Lipsky

Open access · diamondAbstract readReview
In one paragraph

Review in Arthritis research, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. B cell dysregulation in primary Sjögren's syndrome: A review.The Japanese dental science review · 2019
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. A conspicuous role for B cells In Sjögren's syndrome.Clinical reviews in allergy & immunology · 2007
    Review
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Thomas DörnerDepartment of Medicine, Rheumatology and Clinical Immunology, University Hospital Charité, Berlin, Germany. thomas.doemer@charite.de
Peter E Lipsky
Charité - Universitätsmedizin Berlin · DENational Institutes of Health · US

Funding

ROLE OF CD40 LIGAND IN LYMPHOCYTE ACTIVATION, DEVELOPMENT, AND DIFFERENTIATIONP01AI031229 · NIAID · YESHIVA UNIVERSITY · PI DIAMOND, BETTY · 1991 to 2001
$1.6M
NIAID NIH HHS AI 31229
6 · The paper itself

Abstract

Primary Sjögren's syndrome (pSS) is an autoimmune disorder characterized by specific pathologic features and the production of typical autoantibodies. In addition, characteristic changes in the distribution of peripheral B cell subsets and differences in use of immunoglobulin variable-region genes are also features of pSS. Comparison of B cells from the blood and parotid gland of patients with pSS with those of normal donors suggests that there is a depletion of memory B cells from the peripheral blood and an accumulation or retention of these antigen-experienced B cells in the parotids. Because disordered selection leads to considerable differences in the B cell repertoire in these patients, the delineation of its nature should provide important further clues to the pathogenesis of this autoimmune inflammatory disorder.

Indexed as

AutoimmunityB-LymphocytesGene ExpressionHumansImmunoglobulin Variable RegionParotid GlandPhenotypeSjogren's SyndromeImmunoglobulin Variable Region

Identifiers

PMID12453312
PMCPMC153845
OpenAlexW1703840689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.